News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Five Philadelphia Organizations Are Partnering for a New Biotech Technician Training Program Starting this Fall
Five organizations will partner for a paid workforce development training program called Biomedical Technician Training Program: Aseptic Manufacturing.
Penn Engineering Commercialization Speaker Series
This fall, the Penn Center for Innovation and Penn Engineering present three monthly sessions with expert speakers, who will discuss funding, pitching, and open source software for commercialization.
Penn spinout Capstan Therapeutics Launches with Goal of Incorporating mRNA into CAR-T Cell Therapy
This new approach to CAR-T therapy will involve mRNA therapy that directs cells in the body to make proteins to prevent or fight disease.
Tech of the Month: AI-Powered Optical Tool for Fluorescence-Guided Oncological Surgery
This tool provides immediate and accurate tumor identification without the frozen section staining process normally required, saving over 30 minutes and thousands of dollars per tumor per operation.
Jim Wilson Speaks on What’s Next for Cell and Gene Therapy in Philadelphia
On September 8, Jim Wilson, director of Penn Medicine's gene therapy program and director of Penn's orphan disease center. sat down with health care reporter John George for a wide-ranging discussion.
B.PHL Innovation Festival: PCIV Startup VasoWatch LLC and PCI I-Corps Participant Viora Health Featured
The event, which served as a gathering place for local and global creatives, entrepreneurs, leaders, students, and industry changemakers, featured some incredible Penn startups.
Penn Medicine Commercialization Speaker Series – Fall 2022
This fall, the Penn Center for Innovation and Penn Medicine present three monthly speaker sessions with experts in the field of Life Sciences investing, university startups, and intellectual property.
iEcure raises $65M to advance its gene-editing technology and Receives Pediatric Disease Designation from FDA
iEcure raised $65 million to advance its in vivo gene-editing technology aimed at treating rare pediatric liver diseases.
Penn Medicine to Conduct New Clinical Trial to Evaluate Safety and Efficacy of Chewing Gum Designed by School of Dental Medicine Researchers to Trap SARS-CoV-2 in Saliva
The trial will recruit participants from a pool of Penn Medicine employees whose responses to the PennOpen Pass screening system indicate that they may be infected with COVID-19.
SEAS-based Clean Energy Conversions Lab Initiates Carbon Capture Project at Pennovation Works
The Wilcox Lab selects and tests different materials for effective mineral carbonation. The team also compares CO2 uptake based on exterior conditions like air temperature and humidity.